Classification of proteins based on the properties of the ligand-binding site: The case of adenine-binding proteins

Proteins: Structure, Function and Genetics

Volumn 47, Issue 2, 2002, Pages 106-115

  Cappello, Valentina ^a   Tramontano, Anna ^b   Koch, Uwe ^a,c  

^a IRBM   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c NONE   (Italy)

Author keywords

Adenine binding site; Chemogenomics; Drug design; Protein function; Protein structure

Indexed keywords

ADENINE; ADENINE BINDING PROTEIN; AMINE OXIDASE (FLAVIN CONTAINING); AMINO ACID; BINDING PROTEIN; FLAVINE ADENINE NUCLEOTIDE; GLUTATHIONE SYNTHASE; INORGANIC PYROPHOSPHATASE; OXIDOREDUCTASE; PROTEIN SERINE THREONINE KINASE; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; CALCULATION; COMPLEX FORMATION; DRUG DESIGN; HYDROGEN BOND; LIGAND BINDING; MOLECULAR INTERACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN FOLDING; PROTEIN STRUCTURE;

ADENINE; AMINO ACID MOTIFS; ANIMALS; BINDING SITES; DRUG DESIGN; HYDROGEN BONDING; LIGANDS; OXIDOREDUCTASES; PROTEIN FOLDING; PROTEINS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0036568353     PISSN: 08873585     EISSN: None     Source Type: Journal    
DOI: 10.1002/prot.10070     Document Type: Article

References (33)

1. Chemogenomic approaches to drug discovery
2. The relation between the divergence of sequence and structure in proteins
3. The relationship between protein structure and function: A comprehensive survey with application to the yeast genome
4. Protein folds and functions
5. Combining structural genomics and enzymology: Completing the picture in metabolic pathways and enzyme active sites
6. New anilinophthalazines as potent and orally well absorbed inhibitors of the VEGF receptor tyrosine kinases useful as antagonists of tumor-driven angiogenesis
7. Protein kinases: Structure and function
8. Multiple modes of ligand recognition: Crystal structures of cyclin-dependent protein kinase 2 in complex with ATP and two inhibitors, olomoucine and isopentenyladenine
9. 8-Substituted cAMP analogues reveal marked differences in adaptability, hydrogen bonding, and charge accommodation between homologous binding sites (AI/AII and BI/BII) in cAMP kinase I and II
10. Development of a binding model to protein tyrosine kinases for substituted pyrido[2,3-d] pyrimidine inhibitors
11. Computational analysis of PKA-Balanol interactions
12. Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death
13. Inhibitors of HIV-1 reverse transcriptase
14. 1-Arylnaphthalene lignan: A novel scaffold for type 5 phosphodiesterase inhibitor
15. Synthesis of 7-benzylamino-6-chloro-2-piperazino-4-pyrrolidinopteridine and novel derivatives free of positional isomers. Potent inhibitors of cAMP-specific phosphodiesterase and of malignant tumor cell growth
16. Protein recognition of adenylate: An example of a fuzzy recognition template
17. When fold is not important: A common structural framework for adenine and AMP binding in 12 unrelated protein families
18. Enzyme-mononucleotide interactions: Three different folds share common structural elements for ATP recognition
19. Adenine recognition: A motif present in ATP-, CoA-, NAD-, NADP-, and FAD-dependent proteins
20. Molecular approaches to receptors as targets for drug discovery
21. Protein kinase inhibitors: The tyrosine-specific protein kinases
22. The Protein Data Bank: A computer-based archival file for macromolecular structures
23. Databases for protein-ligand complexes
24. Evolution of protein sequences and structures
25. Touring protein fold space with Dali/FSSP
26. CATH a hierarchic classification of protein domain structures
27. SCOP: A structural classification of proteins database for the investigation of sequences and structures
28. The ENZYME database in 2000
29. Automated analysis of interatomic contacts in proteins
30. Characterization of C-H...O hydrogen bonds on the basis of the charge density
31. A role for CH···O interactions in protein-DNA recognition
32. Representation of functional information in the SWISS-PROT data bank
33. Determinants of ligand binding to cAMP-dependent protein kinase